Nigrostriatal alterations in bone morphogenetic protein receptor II dominant negative mice.

[1]  B. Harvey,et al.  Bone morphogenetic protein-7 reduces toxicity induced by high doses of methamphetamine in rodents , 2008, Neuroscience.

[2]  D. Matsuzawa,et al.  The immunophilin ligand FK506 protects against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum , 2005, Neuropharmacology.

[3]  B. Hoffer,et al.  Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease , 2004, Brain Research.

[4]  D. Gash,et al.  Expression of bone morphogenetic proteins in the brain during normal aging and in 6-hydroxydopamine-lesioned animals , 2003, Brain Research.

[5]  Ji-yeon Lee,et al.  Erythropoietin and bone morphogenetic protein 7 mediate ascorbate‐induced dopaminergic differentiation from embryonic mesencephalic precursors , 2003, Neuroreport.

[6]  Eva Lindqvist,et al.  Normal nigrostriatal innervation but dopamine dysfunction in mice carrying hypomorphic tyrosine hydroxylase alleles , 2003, Journal of neuroscience research.

[7]  J. Cadet,et al.  Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method. , 2001, Brain research. Molecular brain research.

[8]  H. Bengtsson,et al.  Expression of serine/threonine kinase receptors including the bone morphogenetic factor type II receptor in the developing and adult rat brain , 1996, Cell and Tissue Research.

[9]  Dennis Higgins,et al.  Osteogenic protein-1 induces dendritic growth in rat sympathetic neurons , 1995, Neuron.